InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Nichtberger Steven, Chairman & CEO. Director active across 1 company, notably Cabaletta Bio, Inc.. Cumulatively, 4 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €239k. Activity tracked since 31 January 2022. The latest transaction was disclosed on 21 January 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Nichtberger Steven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
45,000 shares@ US$2.239530.2% of flowCommon StockSEC:0001193125-26-018318:0
Canonical exit: 21 Apr 2026 (T+90)
8,127 shares@ US$1.24924.3% of flowCommon StockSEC:0000899243-22-033850:0
Canonical exit: 17 Jan 2023 (T+90)
141,873 shares@ US$0.993958.6% of flowCommon StockSEC:0000899243-22-033779:0
Canonical exit: 16 Jan 2023 (T+90)
50,000 shares@ US$1.010.021% mcap50.0% of flowCommon StockSEC:0000899243-22-004158:0
4 of 4 declarations
About Nichtberger Steven
Nichtberger Steven serves as President and Chief Executive Officer of Cabaletta Bio, Inc. In this role, he leads the company's operations and develops strategies to achieve growth objectives. His expertise in the biopharmaceutical field is essential for Cabaletta, which focuses on developing innovative treatments. Nichtberger is committed to improving patient health through advanced therapeutic solutions.
